Markku Jalkanen

USPTO Granted Patents = 16 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

9 out of 14

Faron Pharmaceuticals Oy

patents

7 out of 28

Biotie Therapies Corporation

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371486 - Humanized anti clever-1 antibodies and their use (2025-07-29),

2. 11421279 - Method for determining patient's responsiveness to type 1 interferon treatment and use of type 1 interferon to treat patient having specified single nucleoide polymophism (2022-08-23),

3. 11046761 - Humanized anti clever-1 antibodies and their use (2021-06-29),

4. 10884000 - Method of monitoring the efficacy of the anti-clever-1 therapy in cancer (2021-01-05),

5. 10526607 - Cell and therapeutical and diagnostical methods based thereon (2020-01-07),

6. 10293030 - Lyophilised pharmaceutical formulation and its use (2019-05-21),

7. 10247730 - Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patient (2019-04-02),

8. 8975081 - Biomarker for monitoring development of diseases and assessing the efficacy of therapies (2015-03-10),

9. 8722045 - Cell and therapeutical and diagnostical methods based thereon (2014-05-13),

10. 8119651 - Compositions useful especially for treatment or prevention of metabolic syndrome (2012-02-21),

11. 7399626 - Glucuronyl C5-epimerase, DNA encoding the same and uses thereof (2008-07-15),

12. 6887698 - Glucuronyl C5-epimerase, DNA encoding the same and uses thereof (2005-05-03),

13. 6624202 - Inhibitors of copper-containing amine oxidases (2003-09-23),

14. 6492344 - Syndecan enhancer element and syndecan stimulation of cellular differentiation (2002-12-10),

15. 6017727 - Syndecan enhancer element and syndecan stimulation of cellular (2000-01-25),

Title: Markku Jalkanen - Innovator from Piispanristi, Finland

Introduction: Markku Jalkanen is a renowned inventor hailing from Piispanristi, Finland, known for his groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Markku Jalkanen holds several patents related to novel drug delivery systems and innovative treatment methods for various autoimmune diseases and inflammatory conditions.

Career Highlights: With a distinguished career spanning over three decades, Markku Jalkanen has held key research positions in leading pharmaceutical companies and research institutions, where he has spearheaded numerous projects that have led to significant advancements in the medical field.

Collaborations: Throughout his career, Markku Jalkanen has collaborated with top scientists, researchers, and medical professionals globally, fostering a culture of innovation and knowledge exchange to drive forward cutting-edge solutions for complex medical challenges.

Conclusion: Markku Jalkanen's relentless pursuit of innovation and his passion for improving healthcare outcomes have solidified his reputation as a visionary inventor in the field of biotechnology, leaving a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.